The current Ebola outbreak in the Democratic Republic of Congo has been devastating. Since the outbreak began in mid-May, more than 3,000 people have died.

Almost half of people infected with Ebola are expected to die, and the mortality rate is particularly high for young children. According to a commentary by Doctors Without Borders recently published in medical journal The Lancet, the mortality rate for children under the age of 5 is over 60%.

But often, it’s because of a lack of medication and information on how to use it with young patients, rather than then disease itself.

“Children must be centered in Ebola treatment and prevention research,” the aid organization wrote in early September.

At the heart of the debate is the EBO-PEP study, which began mid-July. The study looks at an experimental antiviral drug called obeldesivir, which is being studied for its ability to protect people exposed to the Bundibugyo Ebola virus, the strain responsible for the current deadly outbreak.

But children weighing less than 30 kilograms (about 66 pounds) and around 12 years old or younger, were not included in the original study. But that could change soon with protocols to include children weighing over 20 kilograms.

HealthDemocratic Republic of Congo

Ebola: Why children are last to be treated in medical crises

In the latest Ebola outbreak in the Democratic Republic of Congo, children are more likely to die than adults. But it’s not always due to the disease. Specific medicines for younger people are often harder to come by.

Congolese medical workers dressed in personal protective equipment (PPE) carry children tested and cleared off from Ebola from Saint Nicholas orphanage.

Children have been badly affected in the current Ebola epidemic, and treatment options for them remain limitedImage: Gradel Muyisa Mumbere/REUTERS

The current Ebola outbreak in the Democratic Republic of Congo has been devastating. Since the outbreak began in mid-May, more than 3,000 people have died.

Almost half of people infected with Ebola are expected to die, and the mortality rate is particularly high for young children. According to a commentary by Doctors Without Borders recently published in medical journal The Lancet, the mortality rate for children under the age of 5 is over 60%.

But often, it’s because of a lack of medication and information on how to use it with young patients, rather than then disease itself.

“Children must be centered in Ebola treatment and prevention research,” the aid organization wrote in early September.

At the heart of the debate is the EBO-PEP study, which began mid-July. The study looks at an experimental antiviral drug called obeldesivir, which is being studied for its ability to protect people exposed to the Bundibugyo Ebola virus, the strain responsible for the current deadly outbreak.

But children weighing less than 30 kilograms (about 66 pounds) and around 12 years old or younger, were not included in the original study. But that could change soon with protocols to include children weighing over 20 kilograms.

Two volunteers wearing personal protective equipment carry the coffin of a 3-year-old child.Two volunteers wearing personal protective equipment carry the coffin of a 3-year-old child.

Children under the age of 5 are significantly more likely to die from Ebola fever than adultsImage: Benediction Murhabazi/AFP

Children weighing less than 20 kilograms — that is, roughly 6 years old or younger — won’t be included in the treatment. There is an alternative treatment for them: Another antiviral drug, remdesivir, given intravenously. But as Doctors Without Borders argued, a 10-day course of infusions is difficult to administer during an outbreak, especially for young children.

According to Neal Russell, a pediatric doctor based in London who consults for Doctors Without Borders and who was also the lead author of the Lancet commentary, young children are at particularly high risk from Ebola. This could be due to their weakened immune systems, underlying health conditions, or the fact that treating them for Ebola is especially challenging in an outbreak.

For example, children are often harder to diagnose than adults because early symptoms resemble other illnesses, and young children often find it difficult to describe their symptoms accurately. Other issues include the fact that children cannot always be accompanied into an Ebola treatment center by their parents or caregivers, something that is especially important in their recovery. Younger Ebola patients also require closer monitoring and specially trained staff.